Juan Manuel Sepúlveda Sánchez (Juan Manuel Sepúlveda, Juan Sepúlveda, Juan M Sepúlveda-Sánchez, Juan Manuel Sepulveda, Juan Sepúlveda-Sánchez, Juan Manuel Sepúlveda-Sánchez, J M Sepúlveda, Juan Manuel Sepulveda-Sanchez)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 12

Top Topics

Cerebrospinal Fluid

Newly Diagnosed

Top Venues

Cancer research

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

This page only lists publications with an associated author ORCID identifier.

Publications

María Angeles Vaz Salgado, Belén Cigarral García, Isaura Fernández Pérez, Beatriz Jiménez Munárriz, Paula Sampedro Domarco, Ainhoa Hernández González, María Vieito Villar, Raquel Luque Caro, María Luisa Villamayor Delgado, Juan Manuel Sepúlveda Sánchez
SEOM-GEINO clinical guidelines for grade 2 gliomas (2023). Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2024)
María José Juan Fita, Urbano Anido Herranz, Maria Jose Mendez, Regina Gironés-Sarrió, José Muñoz Langa, Juan Manuel Sepúlveda Sánchez, Begona Mellado, Carlos Alvarez-Fernandez, Lucía Heras López, Jose Antonio Lopez-Guerrero, Zaida García-Casado, Ana Calatrava, Miguel Ángel Climent
Phase II Trial Evaluating Olaparib Maintenance in Patients with Metastatic Castration-Resistant Prostate Cancer Responsive or Stabilized on Docetaxel Treatment: SOGUG-IMANOL Study. Cancers 15 (21) (2023)
María Angeles Vaz Salgado, Julie Earl, Victor Rodriguez Berrocal, Freddy Salge Arrieta, Ana Gomez, Juan Manuel Sepúlveda Sánchez, Angel Pérez-Nuñez, Elena Corral de la Fuente, Daniel Lourido, María Villamayor, Hector Pian, Alfonso Muriel-Garcia, Elisabetta Rossi, Rita Zamarchi, Alfredo Carrato, Luis Ley
Prognostic value of circulating endothelial cells in glioblastoma patients: a pilot study. Future science OA 8 (5) (2022)
María Martínez-García, Guillermo Velasco, Estela Pineda Losada, Miguel Gil-Gil, Francesc Alameda, Jaume Capellades, Mari Cruz Martín-Soberón, Israel López-Valero, Elena Tovar Ambel, Palmira Foro, Álvaro Taus, Montserrat Arumi, Aurelio Hernández-Laín, Juan Manuel Sepúlveda Sánchez
Safety and Efficacy of Crizotinib in Combination with Temozolomide and Radiotherapy in Patients with Newly Diagnosed Glioblastoma: Phase Ib GEINO 1402 Trial. Cancers 14 (10) (2022)
Berta Segura-Collar, Juan Jiménez-Sanchez, Ricardo Gargini, Miodrag Dragoj, Juan Manuel Sepúlveda Sánchez, Milica Pesic, María A Ramírez, Luis E Ayala-Hernández, Vicente A Torres, Victor M Pérez-García
On optimal temozolomide scheduling for slowly growing glioblastomas. Neuro-oncology advances 4 (1) (2022)
Victor Moreno, Juan Manuel Sepúlveda Sánchez, David A Reardon, Angel Pérez-Nuñez, Pedro González León, Bishoy Hanna, Ellen Filvaroff, Ida Aronchik, Henry Chang, Barbara Amoroso, Marlene Zuraek, Tania Sanchez-Perez, Cristina Mendez, Daniel Stephens, Zariana Nikolova, Michael A Vogelbaum
Trotabresib, an oral potent bromodomain and extraterminal inhibitor, in patients with high-grade gliomas: a phase I, "windowofopportunity" study. Neuro-oncology (2022)
Juan Manuel Sepúlveda Sánchez, Miguel Gil-Gil, Miriam Alonso-García, María Ángeles Vaz Salgado, Elena Vicente, Carlos Mesía Barroso, Ángel Rodríguez Sánchez, Gema Durán, Ramón De Las Peñas, José Muñoz-Langa, Guillermo Velasco, Aurelio Hernández-Laín, Amaya Hilario, Miguel Navarro Martín, Manuel Benavides, Laura Oleaga, Diana Cantero Montenegro, Yolanda Ruano, Pilar Sánchez-Gómez, María Cruz Martín-Soberón, Robert Morales-Llombart, Vanessa Pachón, Estela Pineda
Phase II Trial of Palbociclib in Recurrent Retinoblastoma-Positive Anaplastic Oligodendroglioma: A Study from the Spanish Group for Research in Neuro-Oncology (GEINO). Targeted oncology 15 (5) (2021)
Berta Segura-Collar, María Garranzo-Asensio, Beatriz Herránz, Esther Hernandez-SanMiguel, Teresa Cejalvo, Bárbara S Casas, Ander Matheu, Ángel Pérez-Núñez, Juan Manuel Sepúlveda Sánchez, Aurelio Hernández-Laín, Verónica Palma, Ricardo Gargini, Vicente A Torres
Tumor-Derived Pericytes Driven by EGFR Mutations Govern the Vascular and Immune Microenvironment of Gliomas. Cancer research 81 (8) (2021)
Teresa Cejalvo, Ricardo Gargini, Berta Segura-Collar, Pablo Mata-Martínez, Beatriz Herranz, Diana Cantero, Yolanda Ruano, Daniel García-Pérez, Ángel Pérez-Núñez, Ana Ramos, Aurelio Hernández-Laín, María Cruz Martín-Soberón, Vicente A Torres, Juan Manuel Sepúlveda Sánchez
Immune Profiling of Gliomas Reveals a Connection with IDH1/2 Mutations, Tau Function and the Vascular Phenotype. Cancers 12 (11) (2020)
Julián Pérez-Beteta, David Molina-García, M Villena, M J Rodríguez, Carlos Velasquez, J Martino, Bárbara Meléndez, Á Rodríguez de Lope, R Morcillo, Juan Manuel Sepúlveda Sánchez, Aurelio Hernández-Laín, Ana Ramos, J A Barcia, Pedro Carlos Lara, David Albillo, A Revert, Estanislao Arana, Victor M Pérez-García
Morphologic Features on MR Imaging Classify Multifocal Glioblastomas in Different Prognostic Groups. AJNR. American journal of neuroradiology 40 (4) (2019)
Victor M Pérez-García, Luis E Ayala-Hernández, Juan Belmonte-Beitia, Philippe Schucht, Michael Murek, Andreas Raabe, Juan Manuel Sepúlveda Sánchez
Computational design of improved standardized chemotherapy protocols for grade II oligodendrogliomas. PLoS computational biology 15 (7) (2019)
Juan Manuel Sepúlveda Sánchez, Vicente A Torres, María Ángeles Vaz Salgado, Ricardo Gargini, Carmen Balañá
Dacomitinib: an investigational drug for the treatment of glioblastoma. Expert opinion on investigational drugs 27 (10) (2018)